News

TrueFort, a zero trust application protection company, has secured $30 million in Series B financing.

Lexeo Therapeutics, a clinical-stage gene therapy company, has secured $100 million in Series B financing.

Attralus, Inc., a clinical stage biopharmaceutical company, has secured $116 million in Series B financing.

Flo, an app for a woman's menstrual period and cycle tracking, has secured $65 million in funding.

Mammoth Biosciences, the biotech company, has secured $195 million in financing.

Snyk, a developer security platform, has raised $530 million in Series F funding.

Blendid, a food robotics company, has secured $2 million in funding.

Orchard, a home buying and selling platform, has raised $100 million in Series D funding.

Teatis, a maker of superfood powders for diabetic consumers, has raised $700,000 in seed funding.

Manhattan West taps pension fund veteran Reggie Tucker to lead its venture capital team.